Europe Newborn Screening Market Size & Outlook, 2025-2033
Related Markets
Europe newborn screening market highlights
- The Europe newborn screening market generated a revenue of USD 231.7 million in 2024.
- The market is expected to grow at a CAGR of 7.4% from 2025 to 2033.
- In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2024.
- Electrophoresis is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2025 to 2033.
Europe data book summary
| Market revenue in 2024 | USD 231.7 million |
| Market revenue in 2033 | USD 437.6 million |
| Growth rate | 7.4% (CAGR from 2025 to 2033) |
| Largest segment | Tandem mass spectrometry |
| Fastest growing segment | Electrophoresis |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
| Key market players worldwide | Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp |
Other key industry trends
- In terms of revenue, Europe region accounted for 25.7% of the global newborn screening market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 630.2 million by 2033.
Tandem mass spectrometry was the largest segment with a revenue share of 26.54% in 2024. Horizon Databook has segmented the Europe newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2021 to 2033.
The Newborn Screening (NBS) program is followed across all the European countries. However, alteration in the list of tests and rare disease inclusion by the European Commission has led to preparation of new policies that are in line with the recommendations and requirement of the region. EURORDIS functions as the voice for representing the needs of patients and families within the region.
The European Surveillance of Congenital Anomalies (EUROCAT), established in 1979, maintains registry of epidemiology and evaluates development in pre-natal and newborn screening. According to data published by EUROCAT, over 1.7 million births are screened annually from across 23 countries of EU.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Newborn Screening Market Scope
Newborn Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Covidien | View profile | 10001+ | Dublin, Dublin, Ireland, Europe | http://www.covidien.com |
| Natus Medical | View profile | 1001-5000 | San Carlos, California, United States, North America | http://www.natus.com |
| Agilent Technologies | View profile | 10001+ | Santa Clara, California, United States, North America | http://www.agilent.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Masimo Corp | View profile | 3796 | 52 Discovery, Irvine, CA, United States, 92618 | https://www.masimo.com |
| Waters Corp | View profile | 7900 | 34 Maple Street, Milford, MA, United States, 01757 | https://www.waters.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
Europe newborn screening market size, by country, 2021-2033 (US$M)
Europe Newborn Screening Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
